These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

343 related items for PubMed ID: 25967526

  • 1. Effect of Switching to Travoprost Preserved With SofZia in Glaucoma Patients With Chronic Superficial Punctate Keratitis While Receiving BAK-preserved Latanoprost.
    Aihara M, Ikeda Y, Mizoue S, Arakaki Y, Kita N, Kobayashi S, NEXTraKT Study Group.
    J Glaucoma; 2016 Jun; 25(6):e610-4. PubMed ID: 25967526
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Long-term effect of BAK-free travoprost on ocular surface and intraocular pressure in glaucoma patients after transition from latanoprost.
    Aihara M, Otani S, Kozaki J, Unoki K, Takeuchi M, Minami K, Miyata K.
    J Glaucoma; 2012 Jan; 21(1):60-4. PubMed ID: 21278589
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the toxicity profile of benzalkonium chloride-preserved tafluprost and SofZia-preserved travoprost applied to the ocular surface.
    Kanamoto T, Kiuchi Y, Tanito M, Mizoue S, Naito T, Teranishi S, Hirooka K, Rimayanti U, Ocular Surface Disease and Glaucoma Study Group.
    J Ocul Pharmacol Ther; 2015 Apr; 31(3):156-64. PubMed ID: 25710276
    [Abstract] [Full Text] [Related]

  • 5. Ocular surface tolerability of prostaglandin analogs in patients with glaucoma or ocular hypertension.
    Whitson JT, Trattler WB, Matossian C, Williams J, Hollander DA.
    J Ocul Pharmacol Ther; 2010 Jun; 26(3):287-92. PubMed ID: 20578283
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. From benzalkonium chloride-preserved Latanoprost to Polyquad-preserved Travoprost: a 6-month study on ocular surface safety and tolerability.
    Rossi GC, Scudeller L, Rolle T, Pasinetti GM, Bianchi PE.
    Expert Opin Drug Saf; 2015 May; 14(5):619-23. PubMed ID: 25759110
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Safety and Efficacy of Benzalkonium Chloride-optimized Tafluprost in Japanese Glaucoma Patients With Existing Superficial Punctate Keratitis.
    Suzuki K, Teranishi S, Sagara T, Yoshino H, Nakayama M, Enoki M, Nuno Y, Hirano S, Wakuta M, Takahashi N, Tokuhisa K, Kondo Y, Shiraishi R, Ishida Y, Sonoda KH, Yamaguchi Glaucoma Study Group.
    J Glaucoma; 2015 Aug; 24(6):e145-50. PubMed ID: 24240881
    [Abstract] [Full Text] [Related]

  • 11. Ocular surface tolerability of prostaglandin analogs and prostamides in patients with glaucoma or ocular hypertension.
    Crichton AC, Vold S, Williams JM, Hollander DA.
    Adv Ther; 2013 Mar; 30(3):260-70. PubMed ID: 23475405
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Multicenter, Randomized, Controlled Study Comparing Tafluprost/Timolol Fixed Combination with Latanoprost/Timolol Fixed Combination in Primary Open-Angle Glaucoma and Ocular Hypertension.
    Suzuki K, Otsuka N, Hizaki H, Hashimoto M, Kuwayama Y, Tafluprost/Timolol Versus Latanoprost/Timolol (TTVLT) Study Group.
    Adv Ther; 2018 Jun; 35(6):796-808. PubMed ID: 29873009
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of topical travoprost with sofzia preservative for Japanese glaucoma patients.
    Kanamoto T, Kiuchi Y, Suehiro T, Nakano T, Nakano Y, Hirota A, Miyata A.
    Hiroshima J Med Sci; 2010 Dec; 59(4):71-5. PubMed ID: 21361083
    [Abstract] [Full Text] [Related]

  • 17. Polyquaternium-1-Preserved Travoprost 0.003% or Benzalkonium Chloride-Preserved Travoprost 0.004% for Glaucoma and Ocular Hypertension.
    Peace JH, Ahlberg P, Wagner M, Lim JM, Wirta D, Branch JD.
    Am J Ophthalmol; 2015 Aug; 160(2):266-274.e1. PubMed ID: 25935098
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Duration of IOP reduction with travoprost BAK-free solution.
    Gross RL, Peace JH, Smith SE, Walters TR, Dubiner HB, Weiss MJ, Ochsner KI.
    J Glaucoma; 2008 Aug; 17(3):217-22. PubMed ID: 18414108
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.